Reply to the Letter to the Editor “The Microbiota in Parkinson’s Disease: Ranking the Risk of Heart Disease”
- Standort
-
Deutsche Nationalbibliothek Frankfurt am Main
- Umfang
-
Online-Ressource
- Sprache
-
Englisch
- Erschienen in
-
Reply to the Letter to the Editor “The Microbiota in Parkinson’s Disease: Ranking the Risk of Heart Disease” ; volume:78 ; number:2 ; year:2022 ; pages:119-120 ; extent:2
Annals of nutrition & metabolism ; 78, Heft 2 (2022), 119-120 (gesamt 2)
- Urheber
-
Hirayama, Masaaki
Ohno, Kinji
- DOI
-
10.1159/000521993
- URN
-
urn:nbn:de:101:1-2022041400571164928456
- Rechteinformation
-
Open Access; Der Zugriff auf das Objekt ist unbeschränkt möglich.
- Letzte Aktualisierung
-
15.08.2025, 07:32 MESZ
Datenpartner
Dieses Objekt wird bereitgestellt von:
Deutsche Nationalbibliothek. Bei Fragen zum Objekt wenden Sie sich bitte an den Datenpartner.
Deutsche Nationalbibliothek. Bei Fragen zum Objekt wenden Sie sich bitte an den Datenpartner.
Beteiligte
- Hirayama, Masaaki
- Ohno, Kinji
Ähnliche Objekte (12)
The heterogeneity of Parkinson’s disease
The immunology of Parkinson’s disease
Back to the tubule: microtubule dynamics in Parkinson’s disease
Molecular pathways to Parkinson’s disease
How to optimize the treatment of early stage Parkinson’s disease
The cervical lymph node contributes to peripheral inflammation related to Parkinson’s disease
The prion hypothesis in Parkinson's disease: Braak to the future
Responsiveness of the short-form health survey and the Parkinson’s disease questionnaire in patients with Parkinson’s disease
The neurophysiological brain-fingerprint of Parkinson’s disease
Cannabinoids in the Treatment of Parkinson’s Disease
Parkinson’s Disease, the Dopaminergic Neuron and Gammahydroxybutyrate
Tau in the Pathophysiology of Parkinson’s Disease
The heterogeneity of Parkinson’s disease
The immunology of Parkinson’s disease
Back to the tubule: microtubule dynamics in Parkinson’s disease
Molecular pathways to Parkinson’s disease
How to optimize the treatment of early stage Parkinson’s disease
The cervical lymph node contributes to peripheral inflammation related to Parkinson’s disease
The prion hypothesis in Parkinson's disease: Braak to the future
Responsiveness of the short-form health survey and the Parkinson’s disease questionnaire in patients with Parkinson’s disease
The neurophysiological brain-fingerprint of Parkinson’s disease
Cannabinoids in the Treatment of Parkinson’s Disease
Parkinson’s Disease, the Dopaminergic Neuron and Gammahydroxybutyrate
Tau in the Pathophysiology of Parkinson’s Disease
The heterogeneity of Parkinson’s disease
The immunology of Parkinson’s disease
Back to the tubule: microtubule dynamics in Parkinson’s disease
Molecular pathways to Parkinson’s disease
How to optimize the treatment of early stage Parkinson’s disease
The cervical lymph node contributes to peripheral inflammation related to Parkinson’s disease
The prion hypothesis in Parkinson's disease: Braak to the future
Responsiveness of the short-form health survey and the Parkinson’s disease questionnaire in patients with Parkinson’s disease
The neurophysiological brain-fingerprint of Parkinson’s disease
Cannabinoids in the Treatment of Parkinson’s Disease
Parkinson’s Disease, the Dopaminergic Neuron and Gammahydroxybutyrate